01 — Why it matters
A silent failure of cardiac blood flow.
Deviated flow in the left atrium drives thrombus formation — the dominant mechanism behind ischemic stroke. Today's risk scores miss the patient. The signal lives in the scan.
0M
Atrial fibrillation patients globally
5× folded stroke risk
0M+
Annual strokes worldwide
20% caused by AF
0M+
Annual deaths from stroke
Leading cause of disability
0B€
Global economic burden
Healthcare + lost productivity
04 — Use cases
Built for clinical impact
and scalable distribution.
Stroke risk
Quantitative stroke risk assessment
Augment CHA₂DS₂-VASc with patient-specific stagnation data — identify the silent high-risk patient.
Cardiology
Atrial fibrillation workup
Stratify AF patients beyond rhythm alone — guide anticoagulation and ablation priority decisions.
Triage
Clinical prioritisation
Route urgent cases to specialist review faster, with objective evidence from the scan.
NOAC
Decision support
Inform anticoagulation strategy with a flow-based marker that complements existing risk scores.
Cordicity
More than improved imaging.
Talk to the team building the next quantitative marker in stroke care — whether you are a clinician, a partner, an investor or a future colleague.